Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pitts

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
Translational Vision Science & Technology|November 1, 2022
Neurodegeneration Markers Galectin-3 and Apolipoprotein E Are Elevated in the Aqueous Humor of Eyes With GlaucomaKristen M Pitts, Cameron E Neeson, Nathan E Hall, et al.
Vaccine|August 19, 2008
The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conferenceS Garland, S N Park, H Y S Ngan, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 8, 2023
Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in GlaucomaJonathan B Lin, Kristen M Pitts, Hani El Helwe, et al.
Frontiers in Oncology|May 31, 2017
Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast CancerAnastasia A Ionkina, John J Tentler, Jihye Kim, et al.
Clinical Cancer Drugs|January 12, 2019
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft ModelsAnna R Schreiber, Anna Nguyen, Stacey M Bagby, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early developmentTodd M Pitts, Aik Choon Tan, Gillian N Kulikowski, et al.
Cancers|March 25, 2020
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast CancerTodd M Pitts, Dennis M Simmons, Stacey M Bagby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Overcoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer modelsSara A Flanigan, Todd M Pitts, Timothy P Newton, et al.
Frontiers in Pharmacology|March 26, 2013
Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal CancerErica Lynn Bradshaw-Pierce, Todd M Pitts, Aik-Choon Tan, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
Translational Vision Science & Technology|November 1, 2022
Neurodegeneration Markers Galectin-3 and Apolipoprotein E Are Elevated in the Aqueous Humor of Eyes With GlaucomaKristen M Pitts, Cameron E Neeson, Nathan E Hall, et al.
Vaccine|August 19, 2008
The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conferenceS Garland, S N Park, H Y S Ngan, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 8, 2023
Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in GlaucomaJonathan B Lin, Kristen M Pitts, Hani El Helwe, et al.
Frontiers in Oncology|May 31, 2017
Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast CancerAnastasia A Ionkina, John J Tentler, Jihye Kim, et al.
Clinical Cancer Drugs|January 12, 2019
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft ModelsAnna R Schreiber, Anna Nguyen, Stacey M Bagby, et al.
Breast Cancer Research : BCR|March 1, 2024
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosisStephen G Smoots, Anna R Schreiber, Marilyn M Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early developmentTodd M Pitts, Aik Choon Tan, Gillian N Kulikowski, et al.
Cancers|March 25, 2020
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast CancerTodd M Pitts, Dennis M Simmons, Stacey M Bagby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Overcoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer modelsSara A Flanigan, Todd M Pitts, Timothy P Newton, et al.
Frontiers in Pharmacology|March 26, 2013
Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal CancerErica Lynn Bradshaw-Pierce, Todd M Pitts, Aik-Choon Tan, et al.
Pageof 27